ILiAD Biotechnologies Reports First-ever Demonstration Of Protection Against B. pertussis Colonization In Phase 2b Human Challenge Study Of BPZE1 Vaccine
Network-1 Technologies, Inc. (NYSE:NTIP), a company engaged in the acquisition, development, licensing, and monetization of intellectual property, announced today that ILiAD Biotechnologies, LLC reported the